Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea

BMC Public Health

Table 2 Crude incidence rate (CR) and age-standardized incidence rate (ASR) of oropharyngeal and anogenital cancer

Cancer	Year	Male		Female
Cancer	Year	CR ^b	ASR ^c	CR ^b	ASR ^c
Oropharynx (C01,09,10) ^a	2013	2.7	2.1	0.7	0.5
	2014	2.9	2.1	0.6	0.4
	2015	2.9	2.0	0.7	0.5
	2016	3.1	2.2	0.7	0.5
Anus (C21)	2013	1.5	1.2	1.5	0.9
	2014	1.6	1.2	1.2	0.7
	2015	1.7	1.3	1.3	0.8
	2016	1.5	1.0	1.5	0.9
Vulva (C51)	2013	–	–	0.6	0.4
	2014	–	–	0.6	0.4
	2015	–	–	0.6	0.4
	2016	–	–	0.6	0.4
Vagina (C52)	2013	–	–	0.4	0.3
	2014	–	–	0.4	0.3
	2015	–	–	0.5	0.5
	2016	–	–	0.5	0.3
Penis (C60)	2013	0.2	0.2	–	–
	2014	0.2	0.2	–	–
	2015	0.3	0.2	–	–
	2016	0.3	0.2	–	–

^a Oropharyngeal cancer, including the base of tongue and tonsil
^b Crude incidence rate is calculated per 100,000 persons
^c Age-standardized incidence rate is calculated per 100,000 persons; The age standardization method was a direct method and was adjusted to the World Standard Population of 2000–2025 by WHO

ISSN: 1471-2458